427 related articles for article (PubMed ID: 31563998)
1. Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.
Penke LR; Peters-Golden M
Cell Mol Life Sci; 2019 Nov; 76(21):4179-4201. PubMed ID: 31563998
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
Liguori TTA; Liguori GR; Moreira LFP; Harmsen MC
Sci Rep; 2018 Nov; 8(1):16633. PubMed ID: 30413733
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
[TBL] [Abstract][Full Text] [Related]
5. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
Kramann R; DiRocco DP; Humphreys BD
J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
[TBL] [Abstract][Full Text] [Related]
6. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
[TBL] [Abstract][Full Text] [Related]
7. Methods for Studying Myofibroblast Apoptotic Pathways.
Zhou Y; Lagares D
Methods Mol Biol; 2021; 2299():123-137. PubMed ID: 34028739
[TBL] [Abstract][Full Text] [Related]
8. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
11. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
12. Artesunate inhibits myofibroblast formation via induction of apoptosis and antagonism of pro-fibrotic gene expression in human dermal fibroblasts.
Larson SA; Dolivo DM; Dominko T
Cell Biol Int; 2019 Nov; 43(11):1317-1322. PubMed ID: 31441159
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.
Dolivo DM; Larson SA; Dominko T
Cytokine Growth Factor Rev; 2017 Dec; 38():49-58. PubMed ID: 28967471
[TBL] [Abstract][Full Text] [Related]
14. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
Hinz B; Lagares D
Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of tranilast on the myofibroblast differentiation of rat mesenchymal stem cells induced by transforming growth factor‑β1 in vitro.
Tang W; Zhang Y; Tang L; Zhang J; Xiong L; Wang B
Mol Med Rep; 2018 Dec; 18(6):5693-5700. PubMed ID: 30365138
[TBL] [Abstract][Full Text] [Related]
16. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Fibroblast-to-Myofibroblast Differentiation in Inflammatory Environments and Benefit Cardioprotective Effects.
Shi Y; Yang Y; Guo Q; Gao Q; Ding Y; Wang H; Xu W; Yu B; Wang M; Zhao Y; Zhu W
Stem Cells Dev; 2019 Jun; 28(12):799-811. PubMed ID: 30896296
[TBL] [Abstract][Full Text] [Related]
17. The mechanical memory of lung myofibroblasts.
Balestrini JL; Chaudhry S; Sarrazy V; Koehler A; Hinz B
Integr Biol (Camb); 2012 Apr; 4(4):410-21. PubMed ID: 22410748
[TBL] [Abstract][Full Text] [Related]
18. Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation.
Warsinske HC; Ashley SL; Linderman JJ; Moore BB; Kirschner DE
Bull Math Biol; 2015 Aug; 77(8):1556-82. PubMed ID: 26384829
[TBL] [Abstract][Full Text] [Related]
19. The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis.
Chen X; Shi C; Cao H; Chen L; Hou J; Xiang Z; Hu K; Han X
Cell Death Dis; 2018 May; 9(6):639. PubMed ID: 29844390
[TBL] [Abstract][Full Text] [Related]
20. Pro-fibrotic phenotype of bone marrow stromal cells in Modic type 1 changes.
Heggli I; Epprecht S; Juengel A; Schuepbach R; Farshad-Amacker N; German C; Mengis T; Herger N; Straumann L; Baumgartner S; Betz M; Spirig JM; Wanivenhaus F; Ulrich N; Bellut D; Brunner F; Farshad M; Distler O; Dudli S
Eur Cell Mater; 2021 Jun; 41():648-667. PubMed ID: 34101158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
